Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia - a nationwide, register-based cohort study

CONCLUSIONS: Our findings indicate the importance of considering cannabis-related cases of schizophrenia as a potentially distinct disorder in terms of prognosis. It is unclear, however, if these differences are due to different biological types of schizophrenia being compared or if they rather indicate behavioral differences such as reduced adherence and treatment-seeking.PMID:38571303 | DOI:10.1017/S0033291724000758

Source: Psychological Medicine - April 4, 2024 Category: Psychiatry Authors: Carsten Hjorth øj Anne St ürup Mette Karlsen Helene Speyer Merete Osler Dost Ongur Merete Nordentoft Source Type: research